Safety and Efficacy of Polyethylene Glycol Versus Placebo in the Bowel Preparation for Elective Colorectal Surgeries: A Systemic Review and Meta-Analysis

聚乙二醇与安慰剂在择期结直肠手术肠道准备中的安全性和有效性:系统评价和荟萃分析

阅读:1

Abstract

The most suitable type of preoperative colonic preparation for colorectal surgery is controversial. Polyethylene glycol (PEG) has been widely used and some regard it as more suitable for bowel cleansing. However, it also has some limitations, such as nausea and vomiting. These problems have caused surgeons to question whether bowel cleansing offers any benefit at all. This study aims to assess the safety and efficacy of PEG, compare it with other available bowel preparations, conduct a detailed analysis of the available evidence, and inform clinical practice guidelines for bowel preparation before elective colorectal surgeries. MeSH terms and keywords, including "colorectal surgeries", "polyethylene glycol", and "placebo", were used to run a literature search on PubMed, Embase, Cochrane, and Clinicaltrials.gov from inception to January 2025. Randomized controlled trials (RCTs) comparing PEG with placebo for patients undergoing colorectal surgeries were included. Risk ratios (RRs) and 95% confidence intervals (CIs) were pooled using the Mantel-Haenszel method in RevMan (Cochrane Collaboration, London, UK). Random effects meta-analysis was undertaken. Ten RCTs with a total of 2613 patients were included. Polyethylene showed no significant benefits over placebo regarding quality of bowel preparation (RR = 1.03, 95% CI: 0.91-1.17, p = 0.64) and incidence of surgical site infections (SSIs) (RR = 1.29, 95% CI: 0.95-1.75; p = 0.11). Both groups were comparable in terms of anastomotic leak (RR = 1.14, 95% CI: 0.70-1.85, p = 0.60), intra-abdominal abscess (RR = 0.77, 95% CI: 0.36-1.65, p = 0.50), ileus (RR = 1.16, 95% CI: 0.44-3.05, p = 0.76), anastomotic dehiscence (RR = 0.79, 95% CI: 0.39-1.59, p = 0.51), vomiting (RR = 0.54, 95% CI: 0.27-1.09, p = 0.09), and repeated operations (RR = 0.66, 95% CI: 0.20-2.24, p = 0.51). PEG has no significant benefits over placebo for bowel preparation before colorectal surgeries. Further research and RCTs are necessary to identify and explore other therapeutic options for patients undergoing colorectal surgeries.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。